NCT00849329 - A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2009

Primary Completion Date

November 24, 2009

Study Completion Date

November 24, 2009

Conditions

Neoplasms, Breast

Interventions

DRUG

lapatinib

1250mg lapatinib

DRUG

lapatinib plus esomeprazole

1250mg lapatinib plus esomeprazole 40mg

Trial Locations (4)

GSK Investigational Site, Greenville

GSK Investigational Site, Seoul

GSK Investigational Site, Songpa-gu, Seoul

GSK Investigational Site, Hospitalet de Llobregat (Barcelona)